Wollerau
WOLLERAU, Switzerland, January 7, 2011 - Shield Holdings AG (Shield), the independent specialty
pharmaceutical company focused on the development and commercialisation of
late-stage hospital pharmaceuticals, today announces that Carl Sterritt,
Chief Executive Officer, will present at the Biotech Showcase Conference on
Wednesday 12 January, 2011 at 14:30 PST/ 22:30 GMT at the Parc 55 Wyndham
Union Square Hotel in San Francisco, California.
WOLLERAU, Switzerland, November 1, 2010 - Shield Holdings AG (Shield), the independent specialty
pharmaceutical company focused on the development and commercialisation of
late-stage hospital pharmaceuticals, today announces that it has signed a
strategic commercialisation agreement for its lead asset, ST10-021, an iron
therapy product which has commenced Phase III clinical development, with AOP
Orphan Pharmaceuticals AG ("AOP").
WOLLERAU, Switzerland - Top quality balsamic vinegar and vinegar crystals an asset: the Swiss company Baerg Marti is storing barrique barrels in the Alps for its investors.
